Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association

Arnold, Suzanne V., Bhatt, Deepak L., Barsness, Gregory W., Beatty, Alexis L., Deedwania, Prakash C., Inzucchi, Silvio E., Kosiborod, Mikhail, Leiter, Lawrence A. +4 more·2020·Circulation

Cited by (309)

Items 101–200 of 309

  1. Impact of diabetes on risk of major adverse cardiovascular events associated with lipoprotein(a) levels in patients with established atherosclerotic cardiovascular disease
    Kyuwoong Kim, Min Kyoung Kim, Jiye Han, Hye-Yun Jung, Ah‐Ram Kim, Tae Joon Jun, Younghak Kim · 2025 · European Journal of Preventive Cardiology
  2. The effects of aqueous and ethanolic extracts of Rheum ribes on insulin-resistance and apolipoproteins in patients with type 2 diabetes mellitus: a randomized controlled trial
    Atieh Ghafouri, Sahar Jafari Karegar, Ghazaleh Hajiluian, Sharieh Hosseini, Shahrzad Shidfar, Mohammad Kamalinejad, Agha Fatemeh Hosseini, Iraj Heydari, Farzad Shidfar · 2023 · BMC Complementary Medicine and Therapies
  3. Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
    Tobias Lenz, Tobias Koch, Michael Joner, Erion Xhepa, Jens Wiebe, John Joseph Coughlan, Alp Aytekin, Tareq Ibrahim, Massimiliano Fusaro, Salvatore Cassese et al. · 2021 · Journal of the American Heart Association
  4. Association of diabetes mellitus and glycemic control with left ventricular function and deformation in patients after acute myocardial infarction: a 3 T cardiac magnetic resonance study
    Yue Gao, Rui Shi, Yuan Li, Yingkun Guo, Huayan Xu, Ke Shi, Zhi‐gang Yang · 2023 · Cardiovascular Diabetology
  5. Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis
    Athanasios John Manolis, Manolis S. Kallistratos, Leonidas E. Poulimenos, T. Zamfir, Costas Thomopoulos · 2022 · Hellenic Journal of Cardiology
  6. Impact of diabetes on long‐term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry
    Francesco Bruno, Jeehoon Kang, Edoardo Elia, Jung‐Kyu Han, Ovidio DE FILIPPO, Han‐Mo Yang, Guglielmo Gallone, Kyung Woo Park, Leonardo De Luca, Hyun‐Jae Kang et al. · 2023 · Catheterization and Cardiovascular Interventions
  7. Duration of Dual Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Diabetes: A Systematic Review and Meta-analysis
    Anastasiοs Apostolos, Christofer Travlos, Georgios Tsioulos, David‐Dimitris Chlorogiannis, Αντώνιος Καρανάσος, Michail I. Papafaklis, Dimitrios K. Alexopoulos, Konstantinos G. Toutouzas, Periklis A. Davlouros, Grigorios Tsigkas · 2023 · Journal of Cardiovascular Pharmacology
  8. Effect of Nurse-Led Program in Coronary Heart Diseases Patients: A Systematic Review
    Al Afik, Nursalam Nursalam, Yuni Sufyanti Arif, Riza Fikriana · 2022 · Open Access Macedonian Journal of Medical Sciences
  9. Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry
    Richard Tanner, Serdar Farhan, Gennaro Giustino, Samantha Sartori, Yihan Feng, Amit Hooda, Manish Vinayak, George Dangas, Roxana Mehran, Annapoorna Subhash Kini et al. · 2024 · International Journal of Cardiology
  10. The Evaluation and Management of Coronary Artery Disease in the Lung Transplant Patient
    Gregory W. Serrao, Manish Vinayak, Johny Nicolas, Varsha Subramaniam, Ashton C. Lai, Daniel H. Laskey, Annapoorna Subhash Kini, Harish Seethamraju, Scott A. Scheinin · 2023 · Journal of Clinical Medicine
  11. Aerobic training and vitamin D supplementation effects on diabetes-related parameters in a rat model of type 2 diabetes
    Zahra Hoseini, Nasser Behpour, Rastegar Hoseini · 2025 · BMC Sports Science Medicine and Rehabilitation
  12. Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index
    Xuehua Liu, Tian Zhang, Rong Fu, Dan Liu, Jingyi Zhang, Qing Hu, Guangyao Song, Luping Ren · 2025 · Cardiovascular Diabetology
  13. Pharmacologic Therapies for Type 2 Diabetes
    Bryan Kuo, Josephine H. Li · 2025 · NEJM Evidence
  14. The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
    Olga Alexandrovna Slepova, А. С. Лишута, E. Yu. Vasiltsova, Elena Vitalievna Privalova, Yu. N. Belenkov · 2022 · Rational Pharmacotherapy in Cardiology
  15. Off-pump vs. on-pump bypass surgery grafting in diabetic patients with three-vessel disease: a propensity score matching study
    Yu Song, Chen Wang, Chuanbin Tang, Xiaofan Huang, Dashuai Wang, Rui Li, Jingjing Luo, Yisilamujiang Tuerxun, Yuanming Li, Baoqing Liu et al. · 2023 · Frontiers in Cardiovascular Medicine
  16. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes
    Athanasios John Manolis, Manolis S. Kallistratos, Leonidas E. Poulimenos, Costas Thomopoulos · 2023 · The American Journal of the Medical Sciences
  17. Cost‐Effectiveness of Icosapent Ethyl in REDUCE‐IT USA: Results From Patients Randomized in the United States
    William S. Weintraub, Deepak L. Bhatt, Zugui Zhang, Sarahfaye F. Dolman, William E. Boden, Adam Phillip Bress, Brandon Kyle Bellows, Catherine G. Derington, Sephy Philip, Philippe Gabríel Steg et al. · 2023 · Journal of the American Heart Association
  18. The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort study
    Qinxue Li, Yuan Deshan, Guyu Zeng, Lin Jiang, Lianjun Xu, Jingjing Xu, Ru Liu, Ying Song, Xueyan Zhao, Rutai Hui et al. · 2024 · Diabetes Research and Clinical Practice
  19. The Cardiovascular Benefits of Glucagon-Like Peptide-1 Receptor Agonists as Novel Diabetes Drugs Are Mediated via the Suppression of miR-203a-3p and miR-429 Expression
    Yanfen Liu, Dongying Nie, Xueyong Lou · 2024 · DNA and Cell Biology
  20. 221S-1a inhibits endothelial proliferation in pathological angiogenesis through ERK/c-Myc signaling
    Xinye Yao, Yanbo Xue, Qiang Ma, Yajun Bai, Pu Jia, Yiman Zhang, Baochang Lai, Shuting He, Qiong Ma, Junbo Zhang et al. · 2023 · European Journal of Pharmacology
  21. Brief preoperative frailty predicts postoperative adverse outcomes in older patients with radical esophageal cancer surgery
    Xinyu Hao, Ziyao Xu, Yongxin Guo, Jingjing Liu, Jingyang Tian, Fuyang Cao, Yanping Song, Yanhong Liu, Qiang Fu, Jiangbei Cao et al. · 2025 · BMC Geriatrics
  22. Female Psammomys obesus Are Protected from Circadian Disruption-Induced Glucose Intolerance, Cardiac Fibrosis and Adipocyte Dysfunction
    Joanne T. M. Tan, Cate V. Cheney, Nicole E. S. Bamhare, Tasnim Hossin, Carmel Bilu, Lauren Sandeman, Victoria A. Nankivell, Emma L. Solly, Noga Kronfeld‐Schor, Christina A. Bursill · 2024 · International Journal of Molecular Sciences
  23. Association between the triglyceride-glucose index and the severity of coronary artery disease in patients with type 2 diabetes mellitus and coronary artery disease: a retrospective study
    Jing Li, Zhu Li, Qin Yang · 2024 · Acta Cardiologica
  24. Expert consensus on personalized initiation of glucose‐lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease
    Fang Zhang, Linong Ji, Tianpei Hong, Lixin Guo, Yan Li, Zhiming Zhu, Xingbin Liu, Fang Liu, Lizhi Tang, Yuwei Zhang et al. · 2022 · Journal of Evidence-Based Medicine
  25. Effects of Cardiac Rehabilitation in Cardiopulmonary Fitness with High-Risk Myocardial Infarction
    Seok-Yeon Choi, Ji Hee Kim · 2022 · Healthcare
  26. Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort
    Adrian Włodarczak, Piotr Rola, Mateusz Barycki, Łukasz Furtan, Magdalena Łanocha, Szymon Włodarczak, Marek Szudrowicz, Jan Jakub Kulczycki, Joanna Jaroszewska-Pozorska, Michalina Kędzierska et al. · 2023 · Diabetes and Vascular Disease Research
  27. Triglyceride-glucose Index as a Valuable Marker to Predict Severity of Coronary Artery Disease: A Retrospective Cohort Study
    Xu Geng, Xi Zhang, Xiaowei Li, Chunting Zhong, Min Hou · 2024 · Clinical and Applied Thrombosis/Hemostasis
  28. Coronary revascularization in patients with stable coronary disease and diabetes mellitus
    Salman Zahoor Bhat, Yan Yatsynovich, Umesh C. Sharma · 2021 · Diabetes and Vascular Disease Research
  29. Exercise Reduces Glucose Intolerance, Cardiac Inflammation and Adipose Tissue Dysfunction in Psammomys obesus Exposed to Short Photoperiod and High Energy Diet
    Joanne T. M. Tan, Kiara J. Price, Sarah-Rose Fanshaw, Carmel Bilu, Quang Tuan Pham, Anthony Pham, Lauren Sandeman, Victoria A. Nankivell, Emma L. Solly, Noga Kronfeld‐Schor et al. · 2024 · International Journal of Molecular Sciences
  30. AnchorFCI: harnessing genetic anchors for enhanced causal discovery of cardiometabolic disease pathways
    Adèle H. Ribeiro, Milena Crnkovic, Jaqueline Lopes Pereira, Regina Mara Fisberg, Flávia Mori Sarti, Marcelo Macedo Rogero, Dominik Heider, Andressa Cerqueira · 2024 · Frontiers in Genetics
  31. Implementation of Cardiometabolic Centers and Training Programs
    Mohamad Badie Taha, Neha Rao, Muthiah Vaduganathan, Miguel Cainzos‐Achirica, Khurram Nasir, Kershaw V. Patel · 2022 · Current Diabetes Reports
  32. The effect of dapagliflozin on myocardial ischemia–reperfusion injury in diabetic rats
    Shilong Xiong, Donghua Mo, Yingjun Wu, Peng Wu, Yuanming Hu, Fang Gong · 2023 · Canadian Journal of Physiology and Pharmacology
  33. Exploration of fractional flow reservation score based on artificial intelligence post-processing for coronary artery lesions in patients with diabetes and coronary heart disease
    Mei Li, Likun Zhang, Yingcui Wang, Xiaohong Xu · 2024 · SLAS TECHNOLOGY
  34. Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes
    Qiwei Wilton Sun, Joseph S. Ross · 2024 · JAMA
  35. Metabolomic Profiling Reveals Biomarkers in Coronary Heart Disease Comorbidity
    Chunmei Geng, Benhui Liang, Zihan Kong, Lei Feng, Jianhua Wang, Qingying Si, Pei Jiang · 2024 · Journal of Diabetes Research
  36. Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome
    Stephen A. Clarkson, Brittain F. Heindl, Anping Cai, Timothy Mark Beasley, Chrisly Dillon, Nita A. Limdi, Todd M. Brown · 2021 · The American Journal of Cardiology
  37. Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021).
    F. Arrieta, J. Pedro-Botet, P. Iglesias, J. C. Obaya, Laura Montánez, G. Maldonado, A. Becerra, J. Navarro, J. C. Pérez, Romina Petrecca et al. · 2021 · Clínica e Investigación en Arteriosclerosis
  38. Type 2 diabetes mellitus and In-hospital Major Adverse Cardiac and Cerebrovascular Events (MACCEs) and postoperative complications among patients undergoing on-pump isolated coronary artery bypass surgery in Northeastern Iran
    Mahin Nomali, Aryan Ayati, Amirhossein Tayebi, Mohammad Eghbal Heidari, Keyvan Moghaddam, Soheil Mosallami, Gholamali Riahinokandeh, Mahdis Nomali, Gholamreza Roshandel · 2023 · BMC Cardiovascular Disorders
  39. Long-term Survival Benefit From Revascularization Compared With Medical Therapy in Patients With or Without Diabetes Undergoing Myocardial Perfusion Single Photon Emission Computed Tomography
    Keiichiro Kuronuma, Donghee Han, Robert J.H. Miller, Alan Rozanski, Heidi Gransar, Damini Dey, Sean W. Hayes, John D. Friedman, Louise Thomson, Piotr J. Slomka et al. · 2022 · Diabetes Care
  40. Recent insights into the pathophysiology and implications for surgery in atherosclerosis
    Lingshan Liu, Zhen Wang, Liang Ma, Shengjun Wu · 2025 · Journal of Cardiothoracic Surgery
  41. Effects of auricular acupressure on polysomnography-assessed sleep, blood glucose, and stress in elderly patients with type 2 diabetes and insomnia: a randomized controlled trial
    Jihye Nam, Hye-Jin Lee, Hyojung Park · 2025 · Frontiers in Psychiatry
  42. Protective role of cichoriin and inulin against HFD-STZ-induced diabetic cardiomyopathy in mice via oxidative stress suppression and metabolic modulation
    Nayan Kumar Sishu, Sajan George, Chinnadurai Immanuel Selvaraj · 2026 · Free Radical Biology and Medicine
  43. The Correlation of Serum Uric Acid Levels With the Severity of Coronary Artery Disease in Diabetic Patients: A Cross-Sectional Study
    Sher W Khan, Ayesha Fayyaz, Ikram Ullah, Maryam Shahab, Kainath Naeem, Sheikh Bilal Ahmad, Sayeeda M Shah · 2023 · Cureus
  44. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids
    Hani Mohamed Sabbour, Deepak L. Bhatt, Yaser Elhenawi, Asma Khaled Aljaberi, Layal Bennani, Tarek M. Fiad, Khwaja Yousuf Hasan, Shahrukh Hashmani, Rabih A. Hijazi, Zafar Khan et al. · 2024 · Cardiovascular Drugs and Therapy
  45. Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
    Seung‐Jun Lee, Dong‐Woo Choi, Choongki Kim, Yongsung Suh, Sung‐Jin Hong, Chul‐Min Ahn, Jung‐Sun Kim, Byeong‐Keuk Kim, Young‐Guk Ko, Donghoon Choi et al. · 2022 · Frontiers in Cardiovascular Medicine
  46. Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis
    Zhewei Shi, Caizhen Qian · 2023 · Irish Journal of Medical Science (1971 -)
  47. Increasing trends of overweight and obesity in treatment-naive people living with HIV in Shenzhen from 2014 to 2020: an emerging health concern
    Tian-Ze Li, Liqin Sun, Yun He, Yang Zhou, Liumei Xu, Fang Zhao, Dongsheng Hu, Hui Wang, Hongzhou Lu, Jiaye Liu · 2023 · Frontiers in Public Health
  48. The Synergy of Percutaneous Coronary Intervention and Lifestyle Modification in Reducing Mortality and Blockage Prevention
    Inder Preet Kaur, Kunal Arora, Mayank Dhalani, Meet A Patel, Nishkamni, Guntash Kaur, Rohit Jain · 2024 · Cardiology in Review
  49. Comparison of the RF-CL and CACS-CL models to estimate the pretest probability of obstructive coronary artery disease and predict prognosis in patients with stable chest pain and diabetes mellitus
    Tao Chen, Dujing Shao, Jia Zhao, Mingwen Xiu, Yaoshuang Li, Miao He, Yahang Tan, Yanchun An, Xiangchen Zhang, Jia Zhao et al. · 2024 · Frontiers in Cardiovascular Medicine
  50. Correlation between triglyceride glucose index and coronary plaque: An observational study
    Hai-Yan Jia, Wei-Feng Zhang, Sheng-Qi Jia, Jun Zhang, Ze-Sheng Xu, Zhan-Wen Xu, Yaqin Li · 2024 · Medicine
  51. Circ-0069561 as a novel diagnostic biomarker for progression of diabetic kidney disease
    Chao‐Yi Chen, Xinran Liu, Sai Zhu, Yu–Kai Wang, Yu Ma, Ziyun Hu, Yonggui Wu, Ling Jiang · 2025 · Renal Failure
  52. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus
    Mohammad Omair, Anoop Ninan Koshy, Diem T. Dinh, Angela Brennan, Christopher Michael Reid, Andrew Edward Ajani, Stephen James Duffy, Omar Farouque, M. Yudi, David J. Clark · 2020 · The American Journal of Cardiology
  53. Prognostic value of coronary CT angiography and CT myocardial perfusion imaging among patients with and without Diabetes
    Ruijia Xue, Zilong Ren, Hongliang Zhao, Jingji Xu, Shuangxin Li, Shushen Lin, Jiayi Li, Didi Wen, Minwen Zheng · 2023 · European Journal of Radiology
  54. Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus
    Jianhua Shi, Gaojun Yin, Zhiyun Shi, Shengjun Zhang, Jing Wei, Tao Xue, Xiaoqian Su · 2024 · Endocrine Research
  55. Bitter taste receptor agonists induce vasorelaxation in porcine coronary arteries
    Ching‐Chung Tsai, Yi‐Chen Li, Li-Ching Chang, Shih‐Che Huang · 2025 · Frontiers in Pharmacology
  56. Deep learning-based coronary calcium score derived from non-gated chest CT and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Yidan Xu, Yarong Yu, Xiaoying Ding, Jiajun Yuan, Lihua Yu, Xu Dong Dai, Runjianya Ling, Yufan Wang, Jiayin Zhang · 2025 · Cardiovascular Diabetology
  57. Coronary artery disease patients with rs7904519 (TCF7L2) are at a persistent risk of type 2 diabetes
    Cynthia Al Hageh, Siobhán O’Sullivan, Daniel E. Platt, Andreas Henschel, Stéphanie Chacar, Dominique Gauguier, Antoine Abchee, Eman A. Alefishat, Moni Nader, Pierre Zalloua · 2023 · Diabetes Research and Clinical Practice
  58. Impact of Diabetes Mellitus on Coronary Artery Disease Severity: A Comparative Analysis of Diabetic and Non-diabetic Patients
    Muhammad Muneeb Arshad, Muhammad Jalal-ud-Din, Junaid Qayyum, Masooma Zainab, Ibrahim Shah, Saira Fayyaz, Muhammad Sajid · 2025 · Cureus
  59. The impact of okra on metabolic parameters in Type 2 diabetes patients: Results from a double-blind clinical trial
    Ali Hesamzadeh, Zahra Kashi, Adele Bahar, Majid Saeidi, Atena Ramzani, Rezaaali Mohammad pour Tahamtan · 2025 · Advances in Integrative Medicine
  60. Diabetes: how to manage cardiovascular risk in secondary prevention patients
    Sarah L. Anderson, Joel C. Marrs · 2022 · Drugs in Context
  61. Diabetes and Cardiovascular Disorder
    S. Santhi Priya, Kesavarao Kumar Ebenezar · 2023 · Springer eBooks
  62. Serum IL-38 Level Was Associated with Incidence of MACE in the STEMI Patients
    Chengbo Lu, Fanghui Zhou, Huimin Xian, Siyuan Sun, Jingkun Yue, Ying Zhang, Qi Zhao, Xing Luo, Yang Li · 2023 · International Journal of General Medicine
  63. Mediation effect of antithrombin III between chronic renal insufficiency and chronic coronary artery disease in T2DM patients
    Ruoyu Sun, Jianhong Jia, Shaohua Wang, Zheng Wang, Chenchen Wang, Yanchao Xu, Yuan Yang · 2024 · Endocrine
  64. Risk Factors for Atherosclerotic Cardiovascular Disease
    Carla Weidner, Lynne T. Braun · 2024 · Springer eBooks
  65. From berry to benefit: Harnessing the bioactive properties of red raspberries for combatting metabolic syndrome
    Alejandro Bravo Iniguez, ‬Min Du, Meijun J. Zhu · 2025 · Trends in Food Science & Technology
  66. Effects of Auricular Acupressure on Glycemic Markers, Stress, and Sleep in Older Adult Patients With Type 2 Diabetes: A Randomized Controlled Trial
    Hyejin Lee, Bomi Kim, Hyojung Park · 2025 · Journal of Nursing Research
  67. Icosapent Ethyl (Vascepa®) for the Treatment of Acute, Severe Pancreatitis
    Amnon A. Berger, Robert Sherburne, Ivan Urits, Haresh Patel, Jonathan P. Eskander · 2020 · Cureus
  68. The role of icosapent ethyl in cardiovascular risk reduction
    Ronald Goldenberg, ALICE Y.Y. CHENG, Jeremy D. Gilbert, Eva Lonn, Sue D. Pedersen, Subodh Verma · 2021 · Current Opinion in Cardiology
  69. Short and long-term outcomes after off-pump coronary endarterectomy stratified by different target vessels
    Ying Guang Fang, Wei Hua, Zhen Wu, Wei Liang Song, Changcheng Liu, Haiyang Li, Chengxiong Gu · 2022 · Journal of Cardiothoracic Surgery
  70. The Effect of Female Sex on Short-Term Outcomes of Patients Undergoing Off-Pump Versus On-Pump Coronary Artery Bypass Grafting
    Jun Fan, Shao-ling Luo, Yichao Pan, Tian-yuan Wu, Yu Chen, Wei-jie Li · 2022 · Brazilian Journal of Cardiovascular Surgery
  71. Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina
    Dragana Grujić-Vujmilović, K. Veljković, Ž. Gavrić, Snježana Popović-Pejičić · 2024 · Libyan Journal of Medicine
  72. Association between the triglyceride–glucose index and acute kidney injury in patients undergoing percutaneous coronary: a retrospective analysis of the MIMIC-IV database
    Fan Zhang, Zhan Shen, Lihong Zhang, Xin Zheng, Xiangru Li, Yuzhu Wang · 2025 · Diabetology & Metabolic Syndrome
  73. Diagnosing and treating stable angina: a contemporary approach for practicing physicians
    Athanasios John Manolis, Peter D. Collins, Jose Luis Lopez-Sendon · 2025 · Future Cardiology
  74. Life after Coronary Artery Bypass Grafting: Lifestyle Changes, Secondary Prevention, and Quality of Life
    Jaineet Singh Chhabra, Mohamad I. Mubder, Nadia Tak, Nazanin Houshmand, Arsalan Kabir Siddiqui, Tillmann Cyrus, Tahir Tak · 2025 · International Journal of Angiology
  75. Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis
    Constantin Kuna, E. U. Braun, Christian Bradaric, Tobias Koch, Antonia Presch, Felix Voll, Sebastian Kufner, Tareq Ibrahim, Heribert Schunkert, Karl‐Ludwig Laugwitz et al. · 2025 · Clinical Research in Cardiology
  76. Radiomics of Pericoronary Adipose Tissue and CT-FFR to Predict Major Adverse Cardiovascular Events in Patients with T2DM Complicated by CAD
    Bingcheng Huai, Dixiao Yao, Yi Wang, Jialin Zang, Zonghui Huang, Huiying Yang, Wenchong Li, Dongxu Wang · 2026 · Journal of Cardiovascular Translational Research
  77. Machine learning-selected inflammation biomarkers for stable coronary artery disease with intermediate coronary lesions: potential for long-term prognosis in a multicenter cohort study
    Qiong Xu, Shoupeng Duan, Shuo Liu, Siyang Li, Zongchao Zuo, Jiajun Zhu, Jun Wang · 2026 · Frontiers in Physiology
  78. Exploration of underlying molecular mechanism ofLycii Cortexin Treating Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
    Dongjun Li, Denghui Wang, Shikai Yan · 2021 · E3S Web of Conferences
  79. Individualización del tratamiento de la diabetes mellitus tipo 2
    M. Valero, B. Ugalde, I. Huguet, V. Triviño · 2021 · Medicine - Programa de Formación Médica Continuada Acreditado
  80. Clinical significance of N-terminal natriuretic peptide combined with inflammatory factors, oxidative stress factors and blood lipid detection in elderly patients with Type-2 diabetes complicated with coronary heart disease
    Xiao-min Meng, Shi-xin Kang, Jing Li, Huitao Zhang, Meng Li · 2022 · Pakistan Journal of Medical Sciences
  81. The Presence of Residual Vascular and Adipose Tissue Inflammation on 18F-FDG PET in Patients with Chronic Coronary Artery Disease
    Sini Toivonen, Miia L. Lehtinen, Peter M. Raivio, Juha P. Sinisalo, Antti Loimaala, Valtteri Uusitalo · 2022 · Nuclear Medicine and Molecular Imaging
  82. Clinical Management of Patients With Stable Ischemic Heart Disease
    Subo Dey, Andy Yu-Der Wang, Matthew McMaster, Nirali Sanghavi, William H. Frishman, Wilbert S. Aronow · 2023 · Cardiology in Review
  83. Omega-3 Fatty Acids
    Nickpreet Singh, Erik Dove, Deepak L. Bhatt · 2023 · Elsevier eBooks
  84. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial
    Yasser Jamil, Dae Yong Park, Luis More Verde, Matthew William Sherwood, Behnam N. Tehrani, Wayne Batchelor, Jennifer Frampton, Abdulla A. Damluji, Michael G. Nanna · 2023 · The American Journal of Cardiology
  85. NAD Pathways in Diabetic Coronary Heart Disease: Unveiling the Key Players
    Yuan Liu, Wenjing Zhan, Lexun Wang, Weixuan Wang · 2024 · Current Medicinal Chemistry
  86. Potential roles of IL-38, among other inflammation-related biomarkers, in predicting post-percutaneous coronary intervention cardiovascular events
    Lu Kou, Ning Yang, Bo Dong, Qin Qin · 2024 · Frontiers in Cardiovascular Medicine
  87. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism as a risk factor for premature coronary artery disease in patients with type 2 diabetes mellitus
    Nisreen O. Mohammed, Ibtisam Ahmed Ali, Bahaeldin K. Elamin, B.O. Saeed · 2025 · Frontiers in Endocrinology
  88. Therapeutic effect and potential mechanism of Fufang Danshen dripping pills for stable coronary heart disease: a randomized controlled trial
    Meng Li-qin, Peiying Huang, Qingmin Li, Yuchao Feng, Dong Ming Li, Guohui Wu, Babalghith AO, Guohui Wu, Guoxiong Zhang, Bojun Chen · 2025 · Frontiers in Cardiovascular Medicine
  89. Study on secondary prevention and the impact of risk factor control on myocardial infarction events in young patients with coronary heart disease
    Yidi Liu, Naizhi Geng · 2025 · Medicine
  90. Study on the prevalence of diabetic retinopathy in Pudong New Area and the predictive value of estimated glucose disposal rate: a cross-sectional study
    Jia Gao, Kang Wu, Xiaonan Wang, Zhitao Li, Xiaolin Liu, Jiahui Song, Yang Liu, Hua Qiu, Feng Wei, Qian Xu et al. · 2025 · Frontiers in Endocrinology
  91. Diabetic women: Inpatient mortality risk before SARS-CoV-2
    Maria Cristina Carrondo · 2022 · Obesity Medicine
  92. Associations of serum calcium/magnesium ratios with coronary artery disease in diabetes: a cross-sectional study
    Man Liao, Lijuan Bai, Linfeng He, Ruiyun Wang, Yun Liu, Lihua Liu, Benling Qi · 2022 · Postgraduate Medicine
  93. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry
    Jérémie Abtan, Deepak L. Bhatt, Yedid Elbez, Grégory Ducrocq, Shinya Goto, Sidney C. Smith, E. Magnus Ohman, Kim Allen Eagle, Kim Michael Fox, Robert A. Harrington et al. · 2022 · International Journal of Cardiology
  94. What is really new in triglyceride guidelines?
    Aliza Hussain, Mahmoud Al Rifai, Melody Hermel, Leandro N. Slipczuk, Salim S. Virani · 2023 · Current Opinion in Endocrinology Diabetes and Obesity
  95. Treatment of Patients Chronic Coronary Heart Disease and Type 2 Diabetes Mellitus
    E.V. Shchukina Shchukina, О. А. Приколота, V. A. Bagriy, А. Ю. Андрусяк, Rybalko Gs, Yu. B. Shesterina, Ettori Stefano · 2023 · The Russian Archives of Internal Medicine
  96. Ischemic Heart Disease
    Osama Dasa, Steven M. Smith, Carl J. Pepine · 2023 · Elsevier eBooks
  97. Epidemiology and Clinical Features of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus. Literature Review
    Г. А. Игнатенко, Andrey E. Bagriy, Приколота Алина Вадимовна, О. А. Приколота, E. S. Mykhailichenko, И. А. Аршавская, Kristina E. Mogilevskaya · 2024 · The Russian Archives of Internal Medicine
  98. Effects of Ninjurin 2 polymorphisms on susceptibility to coronary heart disease
    Yuping Yan, Xiaoyan Du, Xia Dou, Jingjie Li, Wenjie Zhang, Shuangyu Yang, Wenting Meng, Gang Tian · 2024 · Cell Cycle
  99. Цукровий діабет і хронічний коронарний синдром
    Victoria A Serhiyenko, Alexandr A. Serhiyenko · 2021 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  100. Tin oxide-chitosan-polyethylene glycol-d-pinitol nanocomposite ameliorates cardiac ischemia in diabetic rats via activating p62/Keap1/Nrf2 signaling
    Rongrong Hou, Tao Yin, Ying Kong, Jia Fang, Wei Jiang, Qiang Yang, Jing Xu · 2022 · Journal of King Saud University - Science